Standard BioTools Inc.
LAB
Price:
$2.03
Market Cap:
$753.44M
Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar reagents, Maxpar direct immune profiling assays, Maxpar on demand reagents, and IMC panel kits for immuno-oncology. The company also provides preparatory instruments, such as Juno systems; and analytical instruments comprising Biomark HD system and EP1 system. In addition, it offers integrated fluidic circuits (IFCs), such as library preparation IFCs,...[Read more]
Industry
Medical - Diagnostics & Research
IPO Date
2011-02-10
Stock Exchange
NASDAQ
Ticker
LAB
The Current Ratio as of September 2024 (TTM) for Standard BioTools Inc. (LAB) is 3.88
According to Standard BioTools Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.88. This represents a change of 18.16% compared to the average of 3.28 of the last 4 quarters.
Standard BioTools Inc. (LAB) Historical Current Ratio (quarterly & annually)
How has LAB Current Ratio performed in the past?
The mean historical Current Ratio of Standard BioTools Inc. over the last ten years is 3.24. The current 3.88 Current Ratio has changed 11.87% with respect to the historical average. Over the past ten years (40 quarters), LAB's Current Ratio was at its highest in in the March 2015 quarter at 6.23. The Current Ratio was at its lowest in in the December 2023 quarter at 1.45.
Average
3.24
Median
3.10
Minimum
1.45
Maximum
5.31
Standard BioTools Inc. (LAB) Current Ratio by Quarter and Year
Discovering the peaks and valleys of Standard BioTools Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 230.61%
Maximum Annual Current Ratio = 5.31
Minimum Annual Increase = -69.89%
Minimum Annual Current Ratio = 1.45
| Year | Current Ratio | Change |
|---|---|---|
| 2023 | 1.45 | -69.89% |
| 2022 | 4.81 | 230.61% |
| 2021 | 1.45 | -32.97% |
| 2020 | 2.17 | -25.92% |
| 2019 | 2.93 | -13.43% |
| 2018 | 3.38 | 19.42% |
| 2017 | 2.83 | -13.58% |
| 2016 | 3.28 | -31.59% |
| 2015 | 4.79 | -9.71% |
| 2014 | 5.31 | -12.50% |
Standard BioTools Inc. (LAB) Average Current Ratio
How has LAB Current Ratio performed in the past?
The current Current Ratio of Standard BioTools Inc. (LAB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
2.57
5-year avg
2.56
10-year avg
3.24
Standard BioTools Inc. (LAB) Current Ratio vs. Peers
How is LAB’s Current Ratio compared to its peers?
Standard BioTools Inc.’s Current Ratio is greater than Star Equity Holdings, Inc. (2.01), greater than Genetron Holdings Limited (1.82), greater than Biodesix, Inc. (3.28), less than ENDRA Life Sciences Inc. (4.97), less than Olink Holding AB (publ) (0), less than FONAR Corporation (5.60), less than MDxHealth SA (9.37), greater than Inotiv, Inc. (0.91), greater than Burning Rock Biotech Limited (0.31), greater than Sera Prognostics, Inc. (3.11), greater than LumiraDx Limited (2.08), greater than Neuronetics, Inc. (1.97), greater than DarioHealth Corp. (2.58), greater than null (2.26),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.01 | $13.05M | |
| 1.82 | $127.29M | |
| 3.28 | $252.61M | |
| 4.97 | $4.24M | |
| 0 | $3.24B | |
| 5.60 | $110.11M | |
| 9.37 | $70.13M | |
| 0.91 | $48.24M | |
| 0.31 | $35.69M | |
| 3.11 | $253.70M | |
| 2.08 | $0 | |
| 1.97 | $28.62M | |
| 2.58 | $27.02M | |
| 2.26 | $0 |
Build a custom stock screener for Standard BioTools Inc. (LAB) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Standard BioTools Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Standard BioTools Inc. (LAB) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Standard BioTools Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the Current Ratio?
How can you use the Current Ratio?
What is Standard BioTools Inc.'s Current Ratio?
How is the Current Ratio calculated for Standard BioTools Inc. (LAB)?
What is the highest Current Ratio for Standard BioTools Inc. (LAB)?
What is the 3-year average Current Ratio for Standard BioTools Inc. (LAB)?
What is the 5-year average Current Ratio for Standard BioTools Inc. (LAB)?
How does the current Current Ratio for Standard BioTools Inc. (LAB) compare to its historical average?